I am a surgical oncologist who specializes in caring for women with breast cancer. I have particular expertise in performing nipple-sparing mastectomies for women with breast cancer and those who are at a high risk of developing the disease. I see patients at MSK Commack and MSK Rockville Centre. At each location, I work closely with my colleagues in radiology, radiation oncology, and medical oncology. We ensure that every person we care for receives a cohesive treatment plan that is tailored to their life and their disease.
Read more Read less
I was drawn to breast oncology because of my interest in advancing women’s health. I greatly value being able to develop relationships with and care for women who are facing a challenging period in their lives. Breast cancer and its treatments affect a woman’s health and can also affect her body image. Because of advancements in treatment options, we are able to cure many women while helping them to continue to look and feel like themselves.
Receiving a breast cancer diagnosis is difficult for women and their loved ones. As their doctor, I want all of my patients to feel that they have a solid understanding of their disease and treatment plan, and to know that I will be by their side throughout their entire journey.
- Clinical Expertise: Breast Cancer; Nipple Sparing Mastectomy
- Awards and Honors: Scientific Impact Presentation Award, American Society of Breast Surgeons (2013); Affinito-Stewart Grant, President's Council for Cornell Women (2014)
- Languages Spoken: English; Spanish
- Education: MD, Stony Brook University School of Medicine
- Residencies: General Surgery – NewYork-Presbyterian/Weill Cornell Medical College
- Fellowships: Breast Surgical Oncology – Memorial Sloan Kettering Cancer Center
- Board Certifications: Surgery
Moo TA, Pinchinat T, Mays S, Landers A, Christos P, Alabdulkareem H, et al. Oncologic Outcomes After Nipple-Sparing Mastectomy. Ann Surg Oncol. 2016 Oct;23(10):3221–5.
Moo TA, McMillian R, Lee M, Stempel M, Ho A, Patil S, El-Tamer M. Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1-T2 breast cancer and 1-3 positive lymph nodes. Ann Surg Oncol 2014 May;21(5):1569-74.
Moo TA, McMillan R, Lee M, Stempel M, Patil S, Ho A, El-Tamer M. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes. Ann Surg Oncol. 2013 Oct;20(10):3169-74.
Read more Read less
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more